o2h Discovery, a leading integrated drug discovery CRO, today announces the launch of the latest edition of o2h Kickstarter Award for Peptide, a dedicated programme/Award designed to support early-stage biotech companies advancing peptide-based therapeutics.
Expanding clinical trials into the EU and UK creates new opportunities for sponsors but also brings complex data protection and legal requirements.
Role Summary
AI hallucinations in drug discovery aren't just an AI problem — they're a data problem.
👉 52% of life science professionals say poor data quality is the #1 barrier to AI implementation
👉 27% of organisations can't even trace the evidence chain powering their AI systems.
In this new white-paper authored by Digital Science's Mark Hahnel we see the practical playbook: FAIR data principles, knowledge graphs, and neuro-symbolic AI for building a foundation pharma can actually trust.
Based in our Discovery Centre on the Cambridge Addenbrookes campus, this Senior Scientist role sits at the heart of Genetic Toxicology, working alongside colleagues in Clinical Pharmacology and Safety Sciences to advance the genotoxicity assessment of new medicines. The position focuses on high-throughput imaging and screening methodologies to generate robust, decision-enabling data that informs safety assessment across drug discovery and development.
Domainex is a leading drug discovery service company located near Cambridge, UK, serving clients across the pharmaceutical, biotechnology, academic, and non-profit sectors worldwide. With a track record of delivering an average of one drug candidate per year over the last six years, Domainex consistently provides high-quality, efficient, and innovative scientific solutions.
Bicycle Therapeutics is a clinical-stage pharmaceutical company developing a novel class of medicines, referred to as Bicycle® molecules, for diseases that are underserved by existing therapeutics. Bicycle molecules are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry. This constraint facilitates target binding with high affinity and selectivity, making Bicycle molecules attractive candidates for drug development.
Want to work for a fast-based biotech working in cutting edge gene therapy? Complement Therapeutics are looking for a clinical trials administrator with a minimum 2year + experience and willingness to learn to join our clinical operations team! If you’re interested, we’d love to hear from you.
Are you an experienced researcher with a background in the central control of obesity and body weight regulation? Would you like to apply your research expertise to accelerate innovative science and turn your ideas into life changing medicines? Join us to discover future treatments of Cardiovascular, Renal and Metabolic (CVRM) diseases!